3rd Quarter - Report

ZERO PROSTATE CANCER for ZERO PROSTATE CANCER

Firm
Client
Income
—
Expenses
$88,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1151 The USPSTF Transparency and Accountability Act - This bipartisan legislation would amend title IX of the Public Health Service Act to require more transparent operations at the United States Preventative Services Task Force. H.R. 1151 would fundamentally reform the Task Force by requiring a balanced and relevant representation of medical personnel, requiring members to disclose conflicts of interest, and requiring consultation with those who treat the specific disease in question.

LobbyistCovered position, as disclosed
MATTHEW MARKS New —
ANDREW SAELENS New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1151 (114th)

Budget/Appropriations BUD

-Prostate Cancer Research Program (PCRP) which is appropriated within the DoD Defense Budget under the Congressionally Directed Medical Research Program (CDMRP) - Center for Disease Control (CDC) funding for prostate cancer control and prevention is appropriated through the Department of Health Human Services

LobbyistCovered position, as disclosed
MATTHEW MARKS New —
ANDREW SAELENS New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.